| Primary |
| Depression |
66.7% |
| Musculoskeletal Pain |
33.3% |
|
| Fear |
33.3% |
| Tremor |
33.3% |
| Vomiting |
33.3% |
|
| Secondary |
| Depression |
44.8% |
| Product Used For Unknown Indication |
20.9% |
| Pain |
9.0% |
| Fibromyalgia |
4.5% |
| Multiple Sclerosis |
4.5% |
| Neuralgia |
4.5% |
| Pruritus |
4.5% |
| Plasma Cell Myeloma |
3.0% |
| Back Pain |
1.5% |
| Oedema Peripheral |
1.5% |
| Type 2 Diabetes Mellitus |
1.5% |
|
| Paraesthesia |
9.1% |
| Weight Increased |
9.1% |
| Atrioventricular Block |
4.5% |
| Blood Pressure Decreased |
4.5% |
| Cholestasis |
4.5% |
| Hypertension |
4.5% |
| Hypoglycaemia |
4.5% |
| Joint Dislocation |
4.5% |
| Neonatal Respiratory Distress Syndrome |
4.5% |
| Nervousness |
4.5% |
| Neuralgia |
4.5% |
| Off Label Use |
4.5% |
| Overdose |
4.5% |
| Platelet Count Decreased |
4.5% |
| Pneumonia |
4.5% |
| Pregnancy |
4.5% |
| Serotonin Syndrome |
4.5% |
| Vision Blurred |
4.5% |
| Vitreous Floaters |
4.5% |
| Vomiting |
4.5% |
|
| Concomitant |
| Multiple Sclerosis |
29.9% |
| Plasma Cell Myeloma |
12.6% |
| Product Used For Unknown Indication |
10.0% |
| Gait Disturbance |
6.5% |
| Osteoporosis |
6.1% |
| Immunodeficiency Common Variable |
4.6% |
| Chronic Myeloid Leukaemia |
3.8% |
| Type 2 Diabetes Mellitus |
3.4% |
| Hepatitis C |
3.1% |
| Relapsing-remitting Multiple Sclerosis |
3.1% |
| Systemic Lupus Erythematosus |
2.3% |
| Hypertension |
1.9% |
| Osteoarthritis |
1.9% |
| Chronic Inflammatory Demyelinating Polyradiculoneuropathy |
1.5% |
| Chronic Obstructive Pulmonary Disease |
1.5% |
| Constipation |
1.5% |
| Myelodysplastic Syndrome |
1.5% |
| Narcolepsy |
1.5% |
| Osteoporosis Prophylaxis |
1.5% |
| Rheumatoid Arthritis |
1.5% |
|
| Vomiting |
15.7% |
| Nausea |
8.3% |
| Pneumonia |
6.5% |
| Pancreatitis |
5.6% |
| Somnolence |
5.6% |
| Tremor |
5.6% |
| Weight Increased |
5.6% |
| Headache |
4.6% |
| Upper Respiratory Tract Infection |
4.6% |
| Diarrhoea |
3.7% |
| Paraesthesia |
3.7% |
| Renal Failure |
3.7% |
| Stress Fracture |
3.7% |
| Urinary Tract Infection |
3.7% |
| Vision Blurred |
3.7% |
| Weight Decreased |
3.7% |
| White Blood Cell Count Decreased |
3.7% |
| Drug Ineffective |
2.8% |
| Hypotension |
2.8% |
| Insomnia |
2.8% |
|
